Statistics
Publications
8
Citations
733
H-Index
8
Active since
2011
Affiliations
Tempus Labs (United States)(Current)
Robert Tell is an author at Tempus Labs (United States) specializing in oncology, molecular oncology, and genomics.
Publications per year
2011–2024
8
8
Clinical validation of the tempus xT next-generation targeted oncology sequencing assay
Nike Beaubier, Robert Tell, Denise Lau et al. · Oncotarget · 2019 · 241 citations · Full text
Life Sciences, Genetics, Oncology +17
Integrated genomic profiling expands clinical options for patients with cancer
Nike Beaubier, Martin Bontrager, Robert Huether et al. · Nature Biotechnology · 2019 · 199 citations
Clinical validation of the Tempus xO assay
Nike Beaubier, Robert Tell, Robert Huether et al. · Oncotarget · 2018 · 61 citations · Full text
1–5 of 8